home / About us / Research Store / Latest reports / Services / NEWS & MEDIA / contact us

Reports

Ideas That Generate Results

Reports by Industry
Reports by Company
Asia Pacific Biotechnology Market (2007-2010)

Asia Pacific Biotechnology Market (2007-2010)

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jun, 2007| No. of Pages : 150

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 1600.00  800.00
CD-ROM Mail Delivery
US$ 1800.00  900.00
Hard Copy Mail Delivery
US$ 1800.00  900.00
Electronic Access - Multi-User License
US$ 2400.00  1200.00
1. Analyst View
 
2. Research Overview
 
3. Biotechnology Industry Overview
       3.1 Market Overview
       3.2 Venture Financing Capital
       3.3 Mergers & Acquisitions
       3.4 US - Growing & Leading the Market
       3.5 Europe - Sustained Recovery
       3.6 Asia-Pacific - Most Promising Region
 
4. Asia-Pacific Biotechnology Market
       4.1 Introduction
       4.2 Market Size
       4.3 Market Segmentation
 
5. Asia-Pacific Biotechnology Market by Country
       5.1 Japan
               5.1.1 Market Overview
               5.1.2 Market Segmentation
               5.1.3 Industry Overview
               5.1.4 Government Role
               5.1.5 Bio-clusters
               5.1.6 Opportunities & Challenges
                        5.1.6.1 Opportunities
                                  5.1.6.1.1 Pharmaceutical Sector
                                  5.1.6.1.2 Medical Devices Market
                                  5.1.6.1.3 In Vitro Diagnostics Market
                                  5.1.6.1.4 Agriculture
                                  5.1.6.1.5 Food & Bioprocessing Industry
                                  5.1.6.1.6 Biotools Market
                                  5.1.6.1.7 Bioinformatics
                                  5.1.6.1.8 Environment Market
                        5.1.6.2 Challenges
                                  5.1.6.2.1 Heavy Burden on the Government
                                  5.1.6.2.2 Lack of Bioventures in Japan
                                  5.1.6.2.3 Lack of Integration between Academic Research & Industry
                                  5.1.6.2.4 Regulatory System
                                  5.1.6.2.5 Laggard in Certain Areas
               5.1.7 Future Outlook (2007-2009)
       5.2 China
               5.2.1 Market Overview
               5.2.2 Market Segmentation
               5.2.3 Industry Overview
               5.2.4 Government Role
               5.2.5 Bio-clusters
               5.2.6 Opportunities & Challenges
                        5.2.6.1 Opportunities
                                  5.2.6.1.1 Biopharmaceuticals
                                  5.2.6.1.2 New Drug Development
                                  5.2.6.1.3 Lab Supplies
                                  5.2.6.1.4 Bio-services
                                  5.2.6.1.5 Chemicals & Enzymes
                                  5.2.6.1.6 Agri & Aquaculture
                                  5.2.6.1.7 Environmental Products & Services
                        5.2.6.2 Challenges
                                  5.2.6.2.1 Overdependence on the Government
                                  5.2.6.2.2 Lack of Coordination between Divisions & Researchers
                                  5.2.6.2.3 Long-term Acceptance of Biotechnology Products
                                  5.2.6.2.4 Regulations Restricting Foreign Investment
                                  5.2.6.2.5 Intellectual Property & Underdeveloped Capital Market
                                  5.2.6.2.6 Lack of Management & Investor Seasoning
               5.2.7 Future Outlook (2007-2009)
       5.3 India
               5.3.1 Market Analysis
               5.3.2 Market Segmentation
               5.3.3 Government Role
               5.3.4 Bio-clusters
               5.3.5 Opportunities & Challenges
                        5.3.5.1 Opportunities
                                  5.3.5.1.1 Outsourcing of Preliminary Research
                                  5.3.5.1.2 Off-patent Drug
                                  5.3.5.1.3 Clinical Trial Market
                                  5.3.5.1.4 Bioinformatics
                                  5.3.5.1.5 Stem Cell Research
                                  5.3.5.1.6 Agricultural Biotechnology
                                  5.3.5.1.7 Biofuel
                                  5.3.5.1.8 Biofertilizers/Biopesticides
                        5.3.5.2 Challenges
                                  5.3.5.2.1 Lack of IPR (Intellectual Property Rights) Regime
                                  5.3.5.2.2 Time to Market
                                  5.3.5.2.3 Seed Funding
                                  5.3.5.2.4 Synergy between Stakeholders
                                  5.3.5.2.5 High Innovative Drug Cost
                                  5.3.5.2.6 Regulatory Issues
               5.3.6 Future Outlook (2007-2010)
       5.4 Australia
               5.4.1 Market Analysis
               5.4.2 Market Segmentation
               5.4.3 Industry Overview
               5.4.4 Government Role
               5.4.5 Bio-clusters
               5.4.6 Opportunities & Challenges
                        5.4.6.1 Opportunities
                                  5.4.6.1.1 Agrobiotechnology
                                  5.4.6.1.2 Health
                                  5.4.6.1.3 Environmental Biotechnology
                                  5.4.6.1.4 Industrial Biotechnology
                                  5.4.6.1.5 Stem Cell Research
                        5.4.6.2 Challenges
                                  5.4.6.2.1 Lack of Commercial Skills
                                  5.4.6.2.2 Lack of Commercial Finesse
                                  5.4.6.2.3 Inability to Market a Product
                                  5.4.6.2.4 Ethical & Consumer Issues
                                  5.4.6.2.5 Cash
               5.4.7 Future Outlook (2007-2010)
       5.5 Taiwan
               5.5.1 Market Analysis
               5.5.2 Market Segmentation
               5.5.3 Market Overview
               5.5.4 Government Role
               5.5.5 Bio-clusters
               5.5.6 Opportunities & Challenges
                        5.5.6.1 Opportunities
                                  5.5.6.1.1 Bioinformatics
                                  5.5.6.1.2 Pharmaceuticals
                                  5.5.6.1.3 Medical Devices
                                  5.5.6.1.4 New Emerging Biotech Sectors
                        5.5.6.2 Challenges
                                  5.5.6.2.1 Inadequate Funding for Research
                                  5.5.6.2.2 Legislations of Certain Laws
                                  5.5.6.2.3 Weak Connection between Laboratories & Factories
                                  5.5.6.2.4 Limited Competition Ability
                                  5.5.6.2.5 Inadequate Understanding of Biotechnology
                                  5.5.6.2.6 Traditional Nursery Companies and GMO Business
                                  5.5.6.2.7 Need for International Co-operation
               5.5.7 Future Outlook (2007-2010) 
       5.6 South Korea
               5.6.1 Market Analysis
               5.6.2 Market Segmentation
               5.6.3 Market Overview
               5.6.4 Government Role
               5.6.5 Bio-clusters
               5.6.6 Opportunities & Challenges
                        5.6.6.1 Opportunities
                                  5.6.6.1.1 International Markets for Drugs
                                  5.6.6.1.2 Embryo Cell Cloning & Human Stem Cell Development
                                  5.6.6.1.3 Developing a Large Pool of Bio-ventures
                                  5.6.6.1.4 Bioinformatics
                                  5.6.6.1.5 Environmental Biotechnology
                                  5.6.6.1.6 Nanobiotechnology
                        5.6.6.2 Challenges
                                  5.6.6.2.1 Dr. Hwang Controversy
                                  5.6.6.2.2 Non-Tariff Barriers to Potential Market Entrants
                                  5.6.6.2.3 Bioethics & Biosafety
                                  5.6.6.2.4 Complicated Distribution Channels
                                  5.6.6.2.5 Lack of Clinical Testing Capabilities
                                  5.6.6.2.6 International Patents
                                  5.6.6.2.7 Weak Knowledge Base
                                  5.6.6.2.8 Inadequate Local Venture Capital or Funds
               5.6.7 Future Outlook (2007-2010)
       5.7 New Zealand
               5.7.1 Market Analysis
               5.7.2 Market Segmentation
               5.7.3 Market Overview
               5.7.4 Government Role
               5.7.5 Bio-clusters
               5.7.6 Opportunities & Challenges
                        5.7.6.1 Opportunities
                                  5.7.6.1.1 Agriculture
                                  5.7.6.1.2 Increased Venture Capital (VC) & Private Equity (PE) Funding
                                  5.7.6.1.3 Environment Biotechnology
                                  5.7.6.1.4 Industrial Biotechnology
                                  5.7.6.1.5 Nanotechnology
                        5.7.6.2 Challenges
                                  5.7.6.2.1 Lack of Support for a Long-term Direction
                                  5.7.6.2.2 Lack of Human Resource
                                  5.7.6.2.3 Commercial Vulnerability
                                  5.7.6.2.4 Reliance on International Companies for Technologies
                                  5.7.6.2.5 Negative Perceptions held by Potential Overseas Investors
               5.7.7 Future Outlook (2007-2010)
       5.8   Singapore
               5.8.1 Market Analysis
               5.8.2 Market Overview
               5.8.3 Government Role
               5.8.4 Bio-clusters
               5.8.5 Opportunities & Challenges
                        5.8.5.1 Opportunities
                                 5.8.5.1.1 Biopharmaceuticals
                                 5.8.5.1.2 Clinical Trials Hub
                                 5.8.5.1.3 Bioinformatics
                                 5.8.5.1.4 Nanotechnology
                                 5.8.5.1.5 Stem Cell Research
                                 5.8.5.1.6 Enabling Technologies
                                 5.8.5.1.7 Intellectual Property
                        5.8.5.2 Challenges
                                 5.8.5.2.1 Venture Funding
                                 5.8.5.2.2 Human Resources
                                 5.8.5.2.3 Low Rate of Survival for Biotechnology Startups
                                 5.8.5.2.4 Lack of Understanding of Life Sciences Ingredients
                                 5.8.5.2.5 Inability to Respond to Changes in the Industry
               5.8.6 Future Outlook (2007-2009)
 
6. Industry Analysis
       6.1 Key Driving Forces
               6.1.1 Strong Government Support 
               6.1.2 Human Resources
               6.1.3 Bio-diversity
               6.1.4 Infrastructure
               6.1.5 Low Cost
       6.2 Opportunities
               6.2.1 Contract Research/Manufacturing
               6.2.2 Vaccines
               6.2.3 Generics
               6.2.4 Biofuel
               6.2.5 Stem Cell Research
               6.2.6 Nanotechnology
Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.

Not readable? Change text.